CLEC-2D Inhibitors
Chemical inhibitors of CLEC-2D operate through various biochemical mechanisms to inhibit the functional activity of this protein. Epigallocatechin gallate, a polyphenolic compound found in green tea, can directly interact with the protein by blocking its ligand-binding sites. This prevents the protein from interacting with its ligands, such as HLA molecules, which are crucial for its signaling function in immune cells. Another inhibitor, Dasatinib, targets the Src family kinases, which are upstream regulators of the signaling pathways involving CLEC-2D. By suppressing these kinases, Dasatinib inhibits the activity of CLEC-2D. Similarly, Sunitinib acts upon receptor tyrosine kinases that are essential for the activation of signaling pathways mediated by CLEC-2D, thus leading to the functional inhibition of the protein.
Other inhibitors, such as Chelerythrine and Bisindolylmaleimide I, focus on inhibiting protein kinase C (PKC). PKC is likely involved in the signal transduction pathways of CLEC-2D, and its inhibition can disrupt the phosphorylation events that are essential for the protein's function. Staurosporine, a broad-spectrum kinase inhibitor, can inhibit various kinases in the signaling pathways associated with CLEC-2D, thus indirectly leading to its functional inhibition. In the same vein, LY333531 specifically inhibits protein kinase C beta, a subset of PKC that may influence CLEC-2D signaling pathways. Inhibitors like U0126 and SB203580 target the MAPK/ERK and p38 MAPK pathways, respectively, which are potentially upstream of CLEC-2D signaling. By inhibiting these kinases, they affect the functional activity of CLEC-2D. Lastly, PI3K inhibitors such as Wortmannin and LY294002 can block pathways involving PI3K, which can lead to downstream functional inhibition of CLEC-2D. Similarly, SP600125, an inhibitor of JNK, can interfere with MAPK signaling pathways involving CLEC-2D, leading to the inhibition of the protein's function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This chemical, a catechin found in green tea, can inhibit the CLEC-2D protein by blocking its ligand-binding sites, thereby preventing interaction with its ligands such as HLA molecules, which is crucial for its function in immune cell signaling. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a tyrosine kinase inhibitor that can inhibit CLEC-2D by suppressing the Src family kinases which are upstream regulators in the signaling pathways in which CLEC-2D is involved, leading to the functional inhibition of the protein's activity. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib can functionally inhibit CLEC-2D by targeting receptor tyrosine kinases involved in the activation of pathways necessary for CLEC-2D-mediated signaling, thus inhibiting the functional activity of CLEC-2D. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is known to inhibit protein kinase C, which is likely involved in signal transduction pathways of CLEC-2D; the inhibition of this kinase can disrupt the phosphorylation events essential for CLEC-2D's function. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, can inhibit various kinases that are part of the signaling pathways associated with CLEC-2D, thus indirectly inhibiting the functional activation of CLEC-2D. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a specific inhibitor of protein kinase C, and by inhibiting PKC, it can impair signaling pathways in which CLEC-2D operates, thus functionally inhibiting the protein. | ||||||
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $94.00 $287.00 | 6 | |
LY333531 is a selective inhibitor of protein kinase C beta, which may be involved in the functional signaling pathways of CLEC-2D, thus its inhibition can lead to functional inhibition of CLEC-2D activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, a kinase involved in the MAPK/ERK pathway, which could be upstream of CLEC-2D signaling pathways. By inhibiting MEK, U0126 can indirectly inhibit the functional activity of CLEC-2D. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK, a kinase that could be involved in signaling pathways with CLEC-2D. Inhibition of p38 MAPK can lead to the functional inhibition of CLEC-2D's activity in these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of PI3K, which is involved in many signaling pathways, including those that could involve CLEC-2D. Inhibition of PI3K can lead to downstream functional inhibition of CLEC-2D. | ||||||